Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

March 1, 2019

Conditions
Alopecia
Interventions
DRUG

CG 428 cutaneous solution

The patient will spray treatment 10 times directly to the scalp area, with the cannula, and then gently massage the whole scalp with fingertips, twice a day, spaced out by minimum 4 hours

DRUG

Placebo cutaneous solution

The patient will spray treatment 10 times directly to the scalp area, with the cannula, and then gently massage the whole scalp with fingertips, twice a day, spaced out by minimum 4 hours

Trial Locations (1)

1011

CHUV Lausanne, Lausanne

Sponsors
All Listed Sponsors
lead

Legacy Healthcare SA

INDUSTRY